Arkolith/Insider Trading/CLSD/Form 4

Hutson Nancy J

DirectorClearside Biomedical, Inc. (CLSD) · full profile →Form 4 · filed Nov 2, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 29, 2021Option exercise(M)15K$2.09$31K53K
Oct 29, 2021Option exercise(M)25K$2.00$50K38K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 29, 2021Option exercise(M)25K—$00
Oct 29, 2021Option exercise(M)15K—$015K

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-21-062427) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML